SLAB

Silicon Labs is now defined by a proposed merger: its risk factors lead entirely with deal-related items — the risk it 'may not complete the proposed Merger,' merger-agreement restrictions on its business, no-shop provisions, and potential litigation. That reframes SLAB from a fundamental investment into a merger-arbitrage situation whose value is anchored to the (undisclosed-here) deal terms and closing probability rather than to a standalone valuation. The 9.2x sales and negative trailing P/E are not the right lens while a transaction is pending.

The underlying business is, encouragingly, in clear cyclical recovery. FY2026 revenue grew 34.3% to $785M as the IoT semiconductor inventory correction reversed, gross profit jumped 46.4% to $457M (a strong 58.2% gross margin), and operating cash flow surged to +$95.7M from near-zero. The net loss narrowed 66.0% to -$64.9M and the operating loss improved to -$70.5M, with R&D sustained at $353M. The balance sheet is pristine — $364M cash, only $175M total liabilities, and a 0.16x liabilities/equity ratio — so the standalone company would have ample runway to reach profitability as volumes normalize.